Richard D Ye Selected Research

Formyl Peptide Receptors (Formyl Peptide Receptor)

1/2020	Structural basis of ligand binding modes at the human formyl peptide receptor 2.
1/2019	Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization.
1/2019	Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer's Disease.
10/2017	4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.
1/2017	The Expression of Formyl Peptide Receptor 1 is Correlated with Tumor Invasion of Human Colorectal Cancer.
5/2011	Characterization of Quin-C1 for its anti-inflammatory property in a mouse model of bleomycin-induced lung injury.
6/2009	International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.
11/2004	A novel nonpeptide ligand for formyl peptide receptor-like 1.
10/2003	Differential activation of formyl peptide receptor signaling by peptide ligands.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard D Ye Research Topics

Disease

27	Inflammation (Inflammations) 11/2020 - 10/2003
7	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 02/2005
7	Infections 01/2020 - 02/2003
7	Acute Lung Injury 01/2020 - 05/2012
5	Neoplasms (Cancer) 01/2020 - 01/2004
5	Pneumonia (Pneumonitis) 01/2019 - 02/2008
5	Edema (Dropsy) 01/2017 - 10/2007
4	Sepsis (Septicemia) 10/2018 - 05/2012
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 01/2016
3	Lung Injury 10/2018 - 02/2008
3	Bacterial Infections (Bacterial Infection) 04/2014 - 12/2007
3	Leukemia 02/2013 - 11/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021 - 01/2016
2	Amyloid Plaque 11/2020 - 01/2014
2	Neoplasm Metastasis (Metastasis) 01/2020 - 03/2009
2	Amyloidosis 12/2014 - 03/2009
2	Vascular System Injuries 10/2009 - 02/2008
2	Thrombosis (Thrombus) 06/2009 - 01/2009
1	Chronic Granulomatous Disease 01/2022
1	Heart Diseases (Heart Disease) 01/2021
1	Cognitive Dysfunction 01/2020
1	Obesity 01/2019
1	Gliosis 01/2019
1	Insulin Resistance 01/2019
1	Gram-Negative Bacterial Infections 10/2018
1	Colitis 01/2018
1	Ischemia 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Idiopathic Pulmonary Fibrosis 01/2017
1	Acute-Phase Reaction 05/2016
1	Lung Diseases (Lung Disease) 01/2016
1	Melanoma (Melanoma, Malignant) 01/2016
1	Right Ventricular Hypertrophy 01/2015
1	Pulmonary Hypertension 01/2015
1	Hypoxia (Hypoxemia) 01/2015
1	Vascular Remodeling 01/2015
1	Peritonitis 09/2014
1	Reperfusion Injury 04/2014

Drug/Important Bio-Agent (IBA)

10	Serum Amyloid A Protein (Serum Amyloid A)IBA 10/2018 - 02/2003
9	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2020 - 10/2003
6	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022 - 11/2008
6	Amyloid (Amyloid Fibrils)IBA 01/2020 - 12/2014
5	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2014 - 02/2003
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2008
4	CytokinesIBA 01/2019 - 07/2008
4	LipopolysaccharidesIBA 10/2018 - 12/2012
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 11/2008
3	Superoxides (Superoxide)IBA 01/2022 - 12/2007
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 05/2011
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2006
3	EnzymesIBA 01/2019 - 11/2004
3	Peptides (Polypeptides)IBA 10/2018 - 02/2013
3	Protein Isoforms (Isoforms)IBA 01/2018 - 12/2014
3	EndotoxinsIBA 06/2012 - 09/2009
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2012 - 03/2009
2	Streptozocin (Streptozotocin)FDA Link 11/2020 - 01/2020
2	LigandsIBA 11/2020 - 09/2006
2	tau Proteins (tau Protein)IBA 01/2020 - 09/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2017
2	ChemokinesIBA 01/2019 - 12/2010
2	Protein Kinases (Protein Kinase)IBA 01/2018 - 01/2016
2	Biological ProductsIBA 03/2017 - 07/2008
2	CollagenIBA 01/2017 - 06/2009
2	Interleukin-10 (Interleukin 10)IBA 02/2016 - 06/2012
2	Mitogen-Activated Protein KinasesIBA 01/2016 - 05/2012
2	Amyloid beta-PeptidesIBA 09/2015 - 02/2005
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2015 - 05/2012
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 06/2012 - 10/2009
2	4- butoxy- N- (2- (4- methoxy- phenyl)- 4- oxo- 1,4- dihydro- 2H- quinazolin- 3- yl)- benzamideIBA 05/2011 - 11/2004
2	Arsenic Trioxide (Trisenox)FDA Link 11/2008 - 01/2004
1	NAD (NADH)IBA 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	osimertinibIBA 03/2021
1	neutrophil cytosolic factor 1IBA 11/2020
1	Presenilin-1IBA 01/2020
1	Protein Kinase CIBA 01/2020
1	AnionsIBA 01/2020
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2020
1	LipidsIBA 01/2019
1	pevonedistatIBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Interleukin-22 (IL-22)IBA 01/2018
1	Dextran SulfateIBA 01/2018
1	4'-hydroxywogoninIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Xylenes (Xylene)IBA 01/2017
1	Interleukin-13IBA 01/2017
1	shikoninIBA 01/2016
1	Macrophage Migration-Inhibitory FactorsIBA 09/2015
1	TOR Serine-Threonine KinasesIBA 01/2015
1	TensinsIBA 01/2015
1	NADP (NADPH)IBA 04/2014
1	chitinase ChiAIBA 03/2013

Therapy/Procedure

1	Therapeutics 01/2020
1	Transplantation 01/2019
1	Punctures 10/2018
1	Ligation 10/2018